Latest News and Press Releases

20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month

Investors who lost money in EMBC after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- IMPORTANT DATE: August 17, 2026. Investors who purchased Embecta Corp. (NASDAQ: EMBC) securities between November 25, 2025 and May 4, 2026 and wish to...

Fort Myers, Fla., June 22, 2026 (GLOBE NEWSWIRE) -- The difference between stroke patients who receive treatment within 60 minutes and those who do not often comes down to protocol decisions,...

New York, NY, June 22, 2026 (GLOBE NEWSWIRE) -- Matrix Applications, a leading provider of financial technology and operational solutions in the capital markets, marks its fourth year earning...

Delray Beach, FL , June 22, 2026 (GLOBE NEWSWIRE) -- The report "Handheld Thermal Camera Market by Profession Type (Electricians, HVAC, Building Inspectors), Distribution Channel (Manufacturer...

TEL AVIV, Israel, June 22, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative...

PHILADELPHIA, June 22, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

Boehringer Ingelheim is committed to improving outcomes for people facing aggressive cancers where there are currently few treatment optionsDAREON®-Lung-1 and DAREON®-NEC-1 will evaluate obrixtamig as...

Investors who lost money in EMBC after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.